ACS
CLB icon

Archford Capital Strategies’s Core Laboratories CLB Stock Holding History

Archford Capital Strategies’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-13
Closed -$1K – 691
2015
Q2 		$1K Hold
13
– – ﹤0.01% 581
2015
Q1 		$1.36K Hold
13
– – ﹤0.01% 602
2014
Q4 		$2K Buy
13
+7
+117% +$919 ﹤0.01% 503
2014
Q3 		$1K Buy
6
+3
+100% +$463 ﹤0.01% 601
2014
Q2 		$501 Buy
+3
New +$534 ﹤0.01% 856

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Archford Capital Strategies's CLB Position: Q3 2015 in Review

Archford Capital Strategies sold out of Core Laboratories (CLB) in Q3 2015, closing a stake of 13 shares — an estimated $1K sold.

Archford Capital Strategies first reported a position in CLB in Q2 2014 and held it in 5 quarters. The position peaked at $2K in Q4 2014. 351 funds tracked by Wall St. Rank hold CLB as of Q3 2015.

  • Archford Capital Strategies reported no remaining Core Laboratories position as of Q3 2015 after selling out during the quarter.
  • Archford Capital Strategies sold 13 Core Laboratories shares in Q3 2015, an estimated $1K.
  • Archford Capital Strategies first reported a position in Core Laboratories in Q2 2014 and held it in 5 quarters.
  • Archford Capital Strategies's Core Laboratories position peaked at $2K in Q4 2014.
  • 351 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2015.

Based on Archford Capital Strategies's 13F filing for Q3 2015, filed 12 Nov 2015.